NxThera Obtains $12,600,000 Series B Round

  • Feed Type
  • Date
    3/16/2011
  • Company Name
    NxThera
  • Mailing Address
    4186 Lexington Ave. St. Paul, MN 55126
  • Company Description
    NxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The company’s technology platform utilizes a simple, minimally invasive, vapor therapy designed to measurably improve urinary flow and patient quality of life.
  • Website
    http://www.nxthera.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $12,600,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The company plans to use this capital to initiate a pivotal BPH clinical study outside of the United States and to obtain CE mark approval needed to support the introduction of its product in the European Economic Area. NxThera also has begun the process of seeking appropriate FDA approvals to undertake a second arm of the BPH clinical study in the U.S.
  • M&A Terms
  • Venture Investor
    American Medical Systems
  • Venture Investor
    Arboretum Ventures
  • Venture Investor
    Aberdare Ventures

By posting a comment, you agree to our terms and conditions.